199 related articles for article (PubMed ID: 880051)
1. Immunotherapy of cancer.
Salmon SE; Jones SE
Ariz Med; 1977 Jun; 34(6):396-8. PubMed ID: 880051
[No Abstract] [Full Text] [Related]
2. Immunotherapy from malignant disease.
Goodnight JE; Morton DL
Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
[No Abstract] [Full Text] [Related]
3. Immunotherapy of cancer: current status.
Goodnight JE; Morton DL
Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637
[No Abstract] [Full Text] [Related]
4. Introduction: Immunotherapy of cancer in man, a reality.
Klein E
Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
[No Abstract] [Full Text] [Related]
5. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
6. Immunotherapy of human tumors.
Sinkovics JG
Pathobiol Annu; 1978; 8():241-84. PubMed ID: 364375
[No Abstract] [Full Text] [Related]
7. [5 years' experience in the immunotherapy of human cancer].
Humphrey LJ; Boehm OR; Boehm BJ; Jewell WR
Zentralbl Chir; 1973 Sep; 98(35):1241-6. PubMed ID: 4784998
[No Abstract] [Full Text] [Related]
8. Clinical trials of immunotherapy: present status.
Morton DL; Goodnight JE
Cancer; 1978 Nov; 42(5):2224-33. PubMed ID: 363256
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy: the unfulfilled promise.
Greco RS
J Med Soc N J; 1981 Jan; 78(1):32-5. PubMed ID: 7021843
[No Abstract] [Full Text] [Related]
10. BCG as adjuvant immunotherapy for neoplasia.
Hersh EM; Gutterman JU; Mavligit GM
Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
[No Abstract] [Full Text] [Related]
11. Immunotherapy of patients with cancer.
Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
[No Abstract] [Full Text] [Related]
12. The current approach to cancer treatment.
Hurley TH; Sullivan JR; Bell R
Aust Fam Physician; 1977 Aug; 6(8):951-6. PubMed ID: 72559
[TBL] [Abstract][Full Text] [Related]
13. An overview of cancer survival in developing countries.
Sankaranarayanan R; Black RJ; Swaminathan R; Parkin DM
IARC Sci Publ; 1998; (145):135-73. PubMed ID: 10194635
[No Abstract] [Full Text] [Related]
14. Immunotherapy as an adjunct to surgery in the treatment of cancer.
Eilber FR; Holmes EC; Morton DL
World J Surg; 1977 Sep; 1(5):547-54. PubMed ID: 602232
[No Abstract] [Full Text] [Related]
15. Immunological response in patients receiving Corynebacterium parvum therapy.
Osborn DE; Castro JE
Clin Oncol; 1977 Jun; 3(2):155-64. PubMed ID: 872468
[No Abstract] [Full Text] [Related]
16. [15 cases of immunotherapy of cancer].
Serrou B; Solassol C; Pujol H; Romieu C
Nouv Presse Med; 1972 Jan; 1(3):197. PubMed ID: 4551478
[No Abstract] [Full Text] [Related]
17. Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.
Schwarz MA; Gutterman JU; Hersh EM; Richman SP; Mavligit GM
World J Surg; 1977 Sep; 1(5):555-83. PubMed ID: 272083
[No Abstract] [Full Text] [Related]
18. Immunotherapy for malignant disease.
Med Lett Drugs Ther; 1976 Sep; 18(20):83-4. PubMed ID: 1066519
[No Abstract] [Full Text] [Related]
19. Active specific immunotherapy of human solid tumors.
Rosato FE; Miller E; Rosato EF
Va Med; 1978 Mar; 105(3):221-3. PubMed ID: 636545
[TBL] [Abstract][Full Text] [Related]
20. Combined modality approaches to cancer therapy. Council on Scientific Affairs.
JAMA; 1984 May; 251(18):2398-407. PubMed ID: 6323778
[No Abstract] [Full Text] [Related]
[Next] [New Search]
